USD $1032.00
Opdivo 40mg Injection is an immunotherapy treatment that harnesses the body's immune system to fight cancer cells. It is primarily used to treat various types of cancers, including melanoma, non-small cell lung cancer, renal cell carcinoma, and more.
Opdivo works by targeting and inhibiting the programmed death-1 (PD-1) receptor on T-cells. By blocking this receptor, Opdivo enhances the immune system's ability to detect and destroy cancer cells, helping to slow down or stop the growth of tumors.
Opdivo is administered intravenously by a healthcare professional. The dosage and schedule depend on the specific condition being treated and the patient's overall health.
Common side effects may include fatigue, nausea, diarrhea, and skin rash. More serious side effects could involve immune-related reactions affecting the lungs, liver, kidneys, or other organs. It is important to discuss potential side effects with a healthcare provider.
Individuals with a history of severe allergic reactions to any components of the injection should avoid using Opdivo. Additionally, patients with certain pre-existing health conditions should consult their healthcare provider before starting treatment.
Opdivo should be stored in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F) and protected from light. It should not be frozen or shaken.
For more detailed information, please consult with a healthcare provider or refer to the official prescribing information provided by the manufacturer.
Health Guides